<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03141567</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00062457</org_study_id>
    <nct_id>NCT03141567</nct_id>
  </id_info>
  <brief_title>LYmphangiogenesis FacTors in Heart Failure States</brief_title>
  <acronym>LYFT-HF</acronym>
  <official_title>LYmphangiogenesis FacTors in Heart Failure States (LYFT-HF Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heart failure often causes fluid to accumulate in the body, leading to congestion and
      swelling. However, some people who have had heart failure for a long time seem to have very
      little congestion or swelling, even when the heart failure is poorly treated. The
      investigators think that this is because lymphatic vessels are able to grow and remove fluid
      to prevent congestion. The investigators do not know how lymphatic vessels grow. This study
      will investigate the blood levels of various proteins to try to figure out how the lymph
      vessels of people with long-standing heart failure might grow.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 18, 2017</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vascular Endothelial Growth Factor (VEGF) Levels</measure>
    <time_frame>At time of right heart catheterization</time_frame>
    <description>VEGF levels in systemic venous, pulmonary arterial, and pulmonary venous samples in participants with left heart failure versus those without left heart failure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lymphangiogenesis factors and Pulmonary Capillary Wedge Pressure (PCWP)</measure>
    <time_frame>At time of right heart catheterization</time_frame>
    <description>Correlation between above lymphangiogenesis factors and pulmonary capillary wedge pressure, right atrial pressure, and cardiac output gathered from right heart catheterization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lymphangiogenesis and Heart failure severity</measure>
    <time_frame>At time of right heart catheterization</time_frame>
    <description>Correlation between lymphangiogenesis factors and heart failure symptom severity as determined by the Kansas City Cardiomyopathy Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lymphangiogenesis and 6 minute hall walk</measure>
    <time_frame>At time of right heart catheterization</time_frame>
    <description>Correlation between lymphangiogenesis factors and 6 minute walk distance.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Heart Failure</condition>
  <condition>Heart Failure With Reduced Ejection Fraction</condition>
  <condition>Heart Failure With Normal Ejection Fraction</condition>
  <arm_group>
    <arm_group_label>Outpatient</arm_group_label>
    <description>Individuals undergoing clinically indicated Right Heart Catheterization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inpatient</arm_group_label>
    <description>Individuals undergoing clinically indicated Right Heart Catheterization.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma or serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All Inpatient and Outpatient individuals undergoing clincially-indicated right heart
        catheterization.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing clinically indicated right heart catheterization.

        Exclusion Criteria:

          -  Unable to provide consent.

          -  Use of medications which may alter lymphangiogenesis factor expression within 365 days

          -  Thalidomide, lenalidomide, pomalidomide

          -  Bevacizumab

          -  Any cytotoxic chemotherapy agents

          -  Pregnant

          -  Any potentially pregnant patient (based on age and gender) undergoes Beta Human
             chorionic gonadotropin testing as standard of care prior to any right heart
             catheterization.

          -  Active cancer within 365 days

          -  Diagnosis of familial or secondary lymphedema

          -  Treatment of active bacterial infection within 7 days

          -  Active inflammatory rheumatologic disease requiring anti-inflammatory therapy
             administration within 60 days

          -  Conditions

          -  Systemic lupus erythematosus

          -  Rheumatoid arthritis

          -  Scleroderma

          -  Inflammatory myositis

          -  Vasculitis

          -  Behcet's disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Houston, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Renee Baxley, RN, BSN</last_name>
    <phone>843-792-1105</phone>
    <email>baxleyr@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kayla Moses, BS</last_name>
    <phone>843-792-5873</phone>
    <email>moseska@musc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ralph H. Johnson VAMC</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2017</study_first_submitted>
  <study_first_submitted_qc>May 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2017</study_first_posted>
  <last_update_submitted>October 4, 2017</last_update_submitted>
  <last_update_submitted_qc>October 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Brian Houston</investigator_full_name>
    <investigator_title>Brian Houston, M.D.</investigator_title>
  </responsible_party>
  <keyword>Lymphangiogenesis</keyword>
  <keyword>Heart Failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

